Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?

2008 ◽  
Vol 62 (8) ◽  
pp. 667-667 ◽  
Author(s):  
M Porta ◽  
B Gonzalez ◽  
S Marquez ◽  
L Artazcoz
2016 ◽  
Vol 214 (6) ◽  
pp. 854-861 ◽  
Author(s):  
Suzette M. Matthijsse ◽  
Jan A. C. Hontelez ◽  
Steffie K. Naber ◽  
Kirsten Rozemeijer ◽  
Inge M. C. M. de Kok ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chengxue Zhong ◽  
Li Xu ◽  
Ho-Lan Peng ◽  
Samantha Tam ◽  
Li Xu ◽  
...  

AbstractIn 2017, 46,157 and 3,127 new oropharyngeal cancer (OPC) cases were reported in the U.S. and Texas, respectively. About 70% of OPC were attributed to human papillomavirus (HPV). However, only 51% of U.S. and 43.5% of Texas adolescents have completed the HPV vaccine series. Therefore, modeling the demographic dynamics and transmission of HPV and OPC progression is needed for accurate estimation of the economic and epidemiological impacts of HPV vaccine in a geographic area. An age-structured population dynamic model was developed for the U.S. state of Texas. With Texas-specific model parameters calibrated, this model described the dynamics of HPV-associated OPC in Texas. Parameters for the Year 2010 were used as the initial values, and the prediction for Year 2012 was compared with the real age-specific incidence rates in 23 age groups for model validation. The validated model was applied to predict 100-year age-adjusted incidence rates. The public health benefits of HPV vaccine uptake were evaluated by computer simulation. Compared with current vaccination program, increasing vaccine uptake rates by 50% would decrease the cumulative cases by 4403, within 100 years. The incremental cost-effectiveness ratio of this strategy was $94,518 per quality-adjusted life year (QALY) gained. Increasing the vaccine uptake rate by 50% can: (i) reduce the incidence rates of OPC among both males and females; (ii) improve the quality-adjusted life years for both males and females; (iii) be cost-effective and has the potential to provide tremendous public health benefits in Texas.


2019 ◽  
Vol 6 (4) ◽  
pp. 317-326
Author(s):  
Gui-Dan Tang ◽  
Gu-Qing Zeng ◽  
Bi-Xia Zhao ◽  
Yun-Li Li ◽  
Rong Wang ◽  
...  

Abstract Objectives To systematically review the knowledge attitudes and the influential factors on human papillomavirus (HPV) vaccination among Chinese women. Methods Published studies on knowledge and attitudes of HPV vaccination for preventing cervical cancer among Chinese female population were retrieved using the major Chinese and English databases. Meanwhile, handwork retrieval was also conducted and the references including in the literature were retrieved. The quality of the literature was rigorously evaluated and extracted independently by two researchers and the data were analyzed and described by review manager 5.3 (RevMan5.3) software. Results In all, 19 articles including 8 articles in Chinese and 11 in English were chosen. A total of 30,176 participants were included and the sample size ranged from 64 to 6,024. The overall awareness of HPV and HPV vaccine among Chinese women was at a low level. Chinese women generally showed poor knowledge about HPV and HPV vaccine. Acceptance of HPV vaccination among Chinese women was at a high level. Vaccination intentions were influenced by the theory of planned behavior (TPB) and measured by attitudes subjective norms and perceived behavioral control. Conclusions The health authorities may evaluate and develop TPB-based interventions to increase HPV vaccination intentions of Chinese women. HPV vaccination programs should focus on carrying out multi-level and targeted health education and developing effective public health strategies after balancing the cost and benefit of HPV vaccine program. Medical staff should play the positive role in promoting the use of HPV vaccines in China. Integration of policy and community perspectives and multi-level interventions are essential to maximize the public health benefits of HPV vaccination.


2021 ◽  
pp. 100014
Author(s):  
Jordan Birebent ◽  
Aurore Palmaro ◽  
Céline Tanios-Dulot ◽  
Damien Driot ◽  
Julie Dupouy ◽  
...  

2011 ◽  
Vol 57 (1) ◽  
pp. 149-158
Author(s):  
Abdelkader El Hasnaoui ◽  
Nadia Demarteau ◽  
Denis Granados ◽  
Baudouin Standaert ◽  
Bruno Detournay

Sign in / Sign up

Export Citation Format

Share Document